Wow! A 14.22% Dividend Yield with 23.05% in upside potential?

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Graphite versus Lithium - What Investors Should Know]( [See why graphite could be the "new lithium"]( --------------------------------------------------------------- June 21, 2023 From the desk of the Editor Dear Reader, We have identified several stocks which are expected to go “Ex-Dividend” very soon. If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. So please keep this in mind. Below is our latest Dividend Report: --------------------------------------------------------------- Sponsor Message [The Ignored EV Story Few Investors Know About]( may grab all the headlines, but the average electric vehicle requires 146 pounds of the mineral graphite. With no producing graphite mines in North America, the U.S. government is desperate for more domestic sources of the metal to feed the EV battery supply chain. [See why "Made in America" graphite should be on every investor's radar]( --------------------------------------------------------------- [Dynex Capital]( Symbol: [DX]( Recent Price: $12.44 Average Analyst Price Target: $14.25 (14.55%) Market Cap: $671.55M Expected Ex-Dividend Date: Jun 22 2023 Expected Payment Date: Jul 03 2023 Expected Dividend & Yield: 12.57% Recent Analyst Action: Eric Hagen, analyst at BTIG, reiterates coverage on [Dynex Capital (DX)]( in the Real Estate sector with a Buy rating and a price target of $15.00 (15 days ago). [TipRanks.com]( also reports that [Dynex Capital]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $14.25. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $13.50. [Dynex Capital (DX)](’s last closing price was $12.44 which would put the average price target at 14.55% upside. Here are 3rd party ratings for [DX](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [AI to Disrupt Energy Market (Huge Potential Gains!)]( orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… It makes them all look like small fries… In fact, just one year of this untapped resource in the USA alone provides 5X as much power as the largest oil field on Earth… And this resource is about to be unleashed on the world like never before with the help of one tiny Silicon Valley company…[Click here for all the details…]( --------------------------------------------------------------- [Finward Bancorp]( Symbol: [FNWD]( Recent Price: $21.65 Average Analyst Price Target: $30.00 (38.57%) Market Cap: $93.01M Expected Ex-Dividend Date: Jun 22 2023 Expected Payment Date: Jul 06 2023 Expected Dividend & Yield: 5.74% Recent Analyst Action: Ben Gerlinger, analyst at Hovde Group, reiterates coverage on [Finward Bancorp (FNWD)]( in the Financial sector with a Hold rating and a price target of $30.00 (2 months ago). [TipRanks.com]( also reports that [Finward Bancorp]( currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $30.00. The target pricing ranges from a high forecast of $30.00 down to a low forecast of $30.00. [Finward Bancorp (FNWD)](’s last closing price was $21.65 which would put the average price target at 38.57% upside. Here are 3rd party ratings for [FNWD](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Bottom 24% (190 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [International Flavors & Fragrances]( Symbol: [IFF]( Recent Price: $79.21 Average Analyst Price Target: $163.40 (31.17%) Market Cap: $20.50B Expected Ex-Dividend Date: Jun 22 2023 Expected Payment Date: Jul 11 2023 Expected Dividend & Yield: 4.01% Recent Analyst Action: Mark Astrachan, analyst at Stifel Nicolaus, reiterates coverage on [International Flavors & Fragrances (IFF)]( in the Consumer Defensive sector with a Sell rating and a price target of $160 (1 year ago). [TipRanks.com]( also reports that [International Flavors & Fragrances]( currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $163.40 . The target pricing ranges from a high forecast of $180.00 down to a low forecast of $147.00. [International Flavors & Fragrances (IFF)](’s last closing price was $79.21 which would put the average price target at 31.17% upside. Here are 3rd party ratings for [IFF](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 23% (193 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [New market event could ruin countless retirements]( This could be a lucrative opportunity if you understand what's happening... but could ruin the retirements of millions of Americans who aren't ready. [DETAILS HERE...]( --------------------------------------------------------------- [Redwood]( Symbol: [RWT]( Recent Price: $6.42 Average Analyst Price Target: $11.17 (23.05%) Market Cap: $737.77M Expected Ex-Dividend Date: Jun 22 2023 Expected Payment Date: Jun 30 2023 Expected Dividend & Yield: 14.22% Recent Analyst Action: JMP Securities, analyst at JMP Securities, reiterates coverage on [Redwood (RWT)]( in the Real Estate sector with a Sell rating and a price target of $9.5 (4 months ago). [TipRanks.com]( also reports that [Redwood]( currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $11.17 . The target pricing ranges from a high forecast of $13.50 down to a low forecast of $9.50. [Redwood (RWT)](’s last closing price was $6.42 which would put the average price target at 23.05% upside. Here are 3rd party ratings for [RWT](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Strong Sell, Bottom 5% (239 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Philip Morris]( Symbol: [PM]( Recent Price: $94.82 Average Analyst Price Target: $119.70 (21.60%) Market Cap: $147.29B Expected Ex-Dividend Date: Jun 22 2023 Expected Payment Date: Jul 11 2023 Expected Dividend & Yield: 5.33% Recent Analyst Action: Stephanie Wissink, analyst at Jefferies, reiterates coverage on [Philip Morris (PM)]( in the Consumer Defensive sector with a Sell rating and a price target of $150 (1 month ago). [TipRanks.com]( also reports that [Philip Morris]( currently has 16 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $119.70 . The target pricing ranges from a high forecast of $150.00 down to a low forecast of $107.00. [Philip Morris (PM)](’s last closing price was $94.82 which would put the average price target at 21.60% upside. Here are 3rd party ratings for [PM](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 46% (115 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Elon Musk May Have Just Changed Everything]( computing, 3D Printing and Gene-Editing... These are three of the most disruptive pieces of technology in recent times... But none of them compare to a project Elon Musk just released...[one that could soon mint the world's first trillionaire...]( --------------------------------------------------------------- [Heartland BancCorp]( Symbol: [HLAN]( Recent Price: $83 Average Analyst Price Target: $96.00 (15.66%) Market Cap: $165.94M Expected Ex-Dividend Date: Jun 22 2023 Expected Payment Date: Jul 10 2023 Expected Dividend & Yield: 3.42% Recent Analyst Action: Brendan Nosal, analyst at Piper Sandler, reiterates coverage on [Heartland BancCorp (HLAN)]( in the Financial sector with a Hold rating and a price target of $96.00 (2 months ago). [TipRanks.com]( also reports that [Heartland BancCorp]( currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $96.00. The target pricing ranges from a high forecast of $96.00 down to a low forecast of $96.00. [Heartland BancCorp (HLAN)](’s last closing price was $83 which would put the average price target at 15.66% upside. Here are 3rd party ratings for [HLAN](: - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Bottom 6% (236 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Global Medical REIT]( Symbol: [GMRE]( Recent Price: $9.48 Average Analyst Price Target: $10.67 (12.55%) Market Cap: $1.87B Expected Ex-Dividend Date: Jun 22 2023 Expected Payment Date: Jul 11 2023 Expected Dividend & Yield: 8.81% Recent Analyst Action: Wes Golladay, analyst at Robert W. Baird, reiterates coverage on [Global Medical REIT (GMRE)]( in the Real Estate sector with a Hold rating and a price target of $9.00 (Last month). [TipRanks.com]( also reports that [Global Medical REIT]( currently has 7 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.67. The target pricing ranges from a high forecast of $11.00 down to a low forecast of $9.00. [Global Medical REIT (GMRE)](’s last closing price was $9.48 which would put the average price target at 12.55% upside. Here are 3rd party ratings for [GMRE](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 31% (172 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Graphite Shortage Could Derail the $7 Trillion EV Transition]( (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles .[See how this could be great news for resource investors]( --------------------------------------------------------------- And there you have it... Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software